253 related articles for article (PubMed ID: 23125011)
1. Incorporation of prognostic and predictive factors into glioma clinical trials.
Johnson DR; Galanis E
Curr Oncol Rep; 2013 Feb; 15(1):56-63. PubMed ID: 23125011
[TBL] [Abstract][Full Text] [Related]
2. Correlative studies in neuro-oncology trials: should they influence treatment?
Hegi ME; Stupp R
Curr Oncol Rep; 2006 Jan; 8(1):54-7. PubMed ID: 16464404
[TBL] [Abstract][Full Text] [Related]
3. Biomarker-based trials in neuro-oncology.
Ballman KV
Chin Clin Oncol; 2015 Sep; 4(3):38. PubMed ID: 26408305
[TBL] [Abstract][Full Text] [Related]
4. Input of molecular analysis in medical management of primary brain tumor patients.
Idbaih A; Duran-Peña A; Bonnet C; Ducray F
Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers usher in era of personalized care for malignant glioma patients.
Chakravarti A; Palanichamy K; Bell EH
CNS Oncol; 2012 Sep; 1(1):3-6. PubMed ID: 25054291
[No Abstract] [Full Text] [Related]
6. Molecular and genetic pathways in gliomas: the future of personalized therapeutics.
Grant R; Kolb L; Moliterno J
CNS Oncol; 2014 Mar; 3(2):123-36. PubMed ID: 25055018
[TBL] [Abstract][Full Text] [Related]
7. On the pathway to success: defining subtypes of gliomas for better treatment selection and refining the meaning of success.
Gilbert MR
Curr Oncol Rep; 2013 Feb; 15(1):24-6. PubMed ID: 23180217
[TBL] [Abstract][Full Text] [Related]
8. Neuro-oncology: Implications of the molecular era.
Ruff MW; Uhm JH; Benarroch EE
Neurology; 2019 Mar; 92(12):568-574. PubMed ID: 30760635
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of biomarker assessment in novel clinical trial designs: personalizing brain tumor treatments.
Galanis E; Wu W; Sarkaria J; Chang SM; Colman H; Sargent D; Reardon DA
Curr Oncol Rep; 2011 Feb; 13(1):42-9. PubMed ID: 21125354
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of clinical responsiveness in brain tumor patients : progress and potential.
El-Jawahri A; Patel D; Zhang M; Mladkova N; Chakravarti A
Mol Diagn Ther; 2008; 12(4):199-208. PubMed ID: 18652516
[TBL] [Abstract][Full Text] [Related]
11. Molecularly based management of gliomas in clinical practice.
Rudà R; Pellerino A; Magistrello M; Franchino F; Pinessi L; Soffietti R
Neurol Sci; 2015 Sep; 36(9):1551-7. PubMed ID: 26194534
[TBL] [Abstract][Full Text] [Related]
12. In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.
Lvu W; Fei X; Chen C; Zhang B
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32725165
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
14. Progress in the study of markers related to glioma prognosis.
Luo Y; Hou WT; Zeng L; Li ZP; Ge W; Yi C; Kang JP; Li WM; Wang F; Wu DB; Wang RY; Qu BL; Li XF; Wang JJ
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7690-7697. PubMed ID: 32744695
[TBL] [Abstract][Full Text] [Related]
15. Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice.
Weller M; Stupp R; Hegi ME; van den Bent M; Tonn JC; Sanson M; Wick W; Reifenberger G
Neuro Oncol; 2012 Sep; 14 Suppl 4(Suppl 4):iv100-8. PubMed ID: 23095825
[TBL] [Abstract][Full Text] [Related]
16. Neuro-oncology in 2015: Progress in glioma diagnosis, classification and treatment.
Wen PY; Reardon DA
Nat Rev Neurol; 2016 Feb; 12(2):69-70. PubMed ID: 26782337
[No Abstract] [Full Text] [Related]
17. Molecular neuro-oncology: a forward-looking perspective.
Wick W; O'Neill T
CNS Oncol; 2013 Nov; 2(6):491-3. PubMed ID: 25054819
[TBL] [Abstract][Full Text] [Related]
18. Proteomics of gliomas: initial biomarker discovery and evolution of technology.
Kalinina J; Peng J; Ritchie JC; Van Meir EG
Neuro Oncol; 2011 Sep; 13(9):926-42. PubMed ID: 21852429
[TBL] [Abstract][Full Text] [Related]
19. Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas.
Ramkissoon LA; Britt N; Guevara A; Whitt E; Severson E; Sathyan P; Gay L; Elvin J; Ross JS; Brown C; Stogner-Underwood K; Mott R; Kram D; Strowd R; Lesser GJ; Ramkissoon SH
Curr Treat Options Oncol; 2018 Jun; 19(8):41. PubMed ID: 29931654
[TBL] [Abstract][Full Text] [Related]
20. Tumor prognostic factors and the challenge of developing predictive factors.
Holliday EB; Sulman EP
Curr Oncol Rep; 2013 Feb; 15(1):33-46. PubMed ID: 23224629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
